231 related articles for article (PubMed ID: 33377184)
41. Extended Sessions of Polymyxin-B Immobilized Fiber Column Hemoperfusion Ameliorate Renal Outcome and Mortality in Septic Shock with Acute Kidney Injury.
Maekawa H; Negishi K
Blood Purif; 2018; 46(2):81-89. PubMed ID: 29672307
[TBL] [Abstract][Full Text] [Related]
42. Impact of hemoperfusion with polymyxin B added to hemofiltration in patients with endotoxic shock: a case-control study.
Navas A; Ferrer R; Martínez ML; Gomà G; Gili G; Masip J; Suárez D; Artigas A
Ann Intensive Care; 2018 Dec; 8(1):121. PubMed ID: 30535929
[TBL] [Abstract][Full Text] [Related]
43. Endotoxin removal therapy with Polymyxin B immobilized fiber column as a COVID-19-bedside strategy protocol for endotoxic shock.
De Rosa S; Zanella M; Samoni S; Ronco C
Front Nephrol; 2022; 2():847305. PubMed ID: 37675016
[TBL] [Abstract][Full Text] [Related]
44. Clinical effects of direct hemoperfusion using a polymyxin-B immobilized column in solid organ transplanted patients with signs of severe sepsis and septic shock. A pilot study.
Ruberto F; Pugliese F; D'Alio A; Martelli S; Bruno K; Marcellino V; Summonti D; Celli P; Perrella S; Cappannoli A; Pietropaoli C; Tosi A; Diana B; Novelli G; Rossi M; Ginanni-Corradini S; Ferretti G; Berloco PB; Pietropaoli P
Int J Artif Organs; 2007 Oct; 30(10):915-22. PubMed ID: 17992653
[TBL] [Abstract][Full Text] [Related]
45. Therapeutic Rationale for Endotoxin Removal with Polymyxin B Immobilized Fiber Column (PMX) for Septic Shock.
Shoji H; Opal SM
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672437
[TBL] [Abstract][Full Text] [Related]
46. Cost-effectiveness analysis of polymyxin-B immobilized fiber column and conventional medical therapy in the management of abdominal septic shock in Italy.
Berto P; Ronco C; Cruz D; Melotti RM; Antonelli M
Blood Purif; 2011; 32(4):331-40. PubMed ID: 22086346
[TBL] [Abstract][Full Text] [Related]
47. Direct hemoperfusion with polymyxin B-immobilized cartridge in severe sepsis due to intestinal perforation: hemodynamic findings and clinical considerations in anticoagulation therapy.
Maynar J; Martínez-Sagasti F; Herrera-Gutiérrez M; Martí F; Candel FJ; Belda J; Castaño S; Sanchez-Izquierdo JÁ
Rev Esp Quimioter; 2013 Jun; 26(2):151-8. PubMed ID: 23817653
[TBL] [Abstract][Full Text] [Related]
48. Anandamide absorption by direct hemoperfusion with polymixin B-immobilized fiber improves the prognosis and organ failure assessment score in patients with sepsis.
Kohro S; Imaizumi H; Yamakage M; Masuda Y; Namiki A; Asai Y; Maruyama I
J Anesth; 2006; 20(1):11-6. PubMed ID: 16421670
[TBL] [Abstract][Full Text] [Related]
49. pH after the first session of direct hemoperfusion with polymyxin B-immobilized fibers predicts mortality in patients with sepsis and septic shock.
Okubo A; Nakashima A; Doi S; Ueno T; Sasaki K; Esaki T; Masaki T
Clin Exp Nephrol; 2018 Oct; 22(5):1167-1173. PubMed ID: 29478200
[TBL] [Abstract][Full Text] [Related]
50. Early induction of direct hemoperfusion with a polymyxin-B immobilized column is associated with amelioration of hemodynamic derangement and mortality in patients with septic shock.
Chihara S; Masuda Y; Tatsumi H; Nakano K; Shimada T; Murohashi T; Yamakage M
J Artif Organs; 2017 Mar; 20(1):71-75. PubMed ID: 27469940
[TBL] [Abstract][Full Text] [Related]
51. Polymyxin B hemoperfusion in clinical practice: the picture from an unbound collaborative registry.
Early Use of Polymyxin B Hemoperfusion in the Abdominal Sepsis 2 Collaborative Group
Blood Purif; 2014; 37 Suppl 1():22-5. PubMed ID: 24457492
[TBL] [Abstract][Full Text] [Related]
52. A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection.
Vincent JL; Laterre PF; Cohen J; Burchardi H; Bruining H; Lerma FA; Wittebole X; De Backer D; Brett S; Marzo D; Nakamura H; John S
Shock; 2005 May; 23(5):400-5. PubMed ID: 15834304
[TBL] [Abstract][Full Text] [Related]
53. Angiopoietin Balance in Septic Shock Patients With Acute Kidney Injury: Effects of Direct Hemoperfusion With Polymyxin B-Immobilized Fiber.
Ebihara I; Hirayama K; Nagai M; Shiina E; Koda M; Gunji M; Okubo Y; Sato C; Usui J; Yamagata K; Kobayashi M
Ther Apher Dial; 2016 Aug; 20(4):368-75. PubMed ID: 27523077
[TBL] [Abstract][Full Text] [Related]
54. Polymyxin B hemoperfusion as a feasible therapy after source control in abdominal septic shock.
Kim JJ; Park YJ; Moon KY; Park JH; Jeong YK; Kim EY
World J Gastrointest Surg; 2019 Dec; 11(12):422-432. PubMed ID: 31879534
[TBL] [Abstract][Full Text] [Related]
55. Effects of hemoperfusion with polymyxin B-immobilized fibre on serum neopterin and soluble interleukin-2 receptor concentrations in patients with septic shock.
Nakamura T; Ebihara I; Shimada N; Suzuki S; Ushiyama C; Shoji H; Koide H
J Infect; 1998 Nov; 37(3):241-7. PubMed ID: 9892527
[TBL] [Abstract][Full Text] [Related]
56. Clinical effects of use polymyxin B fixed on fibers in liver transplant patients with severe sepsis or septic shock.
Ruberto F; Pugliese F; D'Alio A; Martelli S; Bruno K; Marcellino V; Perrella S; Cappannoli A; Mazzarino V; Tosi A; Novelli G; Rossi M; Ginanni Corradini S; Ferretti G; Berloco PB; Pietropaoli P
Transplant Proc; 2007; 39(6):1953-5. PubMed ID: 17692664
[TBL] [Abstract][Full Text] [Related]
57. Exacerbation of prothrombin time-international normalized ratio before second polymyxin B cartridge hemoperfusion predicts poor outcome of patients with severe sepsis and/or septic shock.
Ishizuka M; Terasaki A; Kubota K
J Surg Res; 2016 Jan; 200(1):308-14. PubMed ID: 26319975
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of postoperative polymyxin B hemoperfusion in secondary peritonitis patients with septic shock: a propensity-matched analysis.
Yuan KC; Wang SY; Yu MC; Hsu YP; Pan HC; Chen YC
Int J Artif Organs; 2017 Feb; 39(12):603-610. PubMed ID: 28165586
[TBL] [Abstract][Full Text] [Related]
59. Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application.
Shoji H; Tani T; Hanasawa K; Kodama M
Ther Apher; 1998 Feb; 2(1):3-12. PubMed ID: 10227782
[TBL] [Abstract][Full Text] [Related]
60. Polymyxin B-immobilized fiber column hemoperfusion removes endotoxin throughout a 24-hour treatment period.
Mitaka C; Fujiwara N; Yamamoto M; Toyofuku T; Haraguchi G; Tomita M
J Crit Care; 2014 Oct; 29(5):728-32. PubMed ID: 24798345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
